School of Medicine


Showing 1-89 of 89 Results

  • Lusine Aghajanova, M.D., Ph.D.

    Lusine Aghajanova, M.D., Ph.D.

    Clinical Professor, Obstetrics & Gynecology - Reproductive Endocrinology & Infertility

    BioDr. Aghajanova received her medical degree from Yerevan State Medical University in Armenia, followed by residency in obstetrics and gynecology, then completed PhD in Human Implantation at Karolinska Institute, Stockholm, Sweden, followed with embryology training at Karolinska Institute, with an Internship in Austria.
    She continued her research as a postdoctoral fellow at the University of California San Francisco.

    Subsequently, Dr. Aghajanova completed residency in Obstetrics and Gynecology at Baylor College of Medicine, Houston, Texas and at UC San Francisco. She proceeded then with subspecialty fellowship training in Reproductive Endocrinology and Infertility at UC San Francisco. Dr Aghajanova joined Stanford in 2017. She is a respected researcher in the field of endometrial receptivity, implantation and endometriosis, as well as access to reproductive care. She is the Program Director for REI fellowship at Stanford Medicine. She is also Director of Thirds Party Reproduction at Stanford Fertility and Reproductive Care.

    Dr. Aghajanova speaks Russian and Armenian and is very well published with over 90 peer-reviewed publications as well as numerous other oral and poster presentations and is a professional peer-reviewer for over 12 journals, including Nature Journals and leading journals in field of reproduction.

    Dr.Aghajanova enjoys spending time with her husband and children, and traveling.

  • Meghali Aich

    Meghali Aich

    Postdoctoral Scholar, Neonatal and Developmental Medicine

    BioMy research interest lies in understanding how environmental factors contribute to neurodevelopmental disorders and translating those insights into therapies. Aligned with this, my current research in Brain Therapeutics lab at Stanford focuses on how reductive stress associated with maternal metabolic syndrome affects fetal brain development.

  • Jacob S. Ballon, MD, MPH

    Jacob S. Ballon, MD, MPH

    Associate Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)

    BioJacob S. Ballon, M.D., M.P.H. specializes in the treatment of people with psychotic disorders including schizophrenia. He is the Co-Director of the INSPIRE Clinic at Stanford which provides interdisciplinary care for people experiencing psychosis. He is also the Associate Chair for Patient Services and co-Division Chief for General Adult Psychiatry and Psychology in the Department of Psychiatry. Dr. Ballon completed his residency at Stanford in 2009 and a Schizophrenia Research Fellowship at Columbia University in 2011.

    Dr. Ballon's research focuses primarily in clinical trials of new medications for the treatment of schizophrenia. He further maintains an interest in understanding the connections between the brain and the rest of the body as relates to the manifestation and treatment of people who experience psychosis. He works closely with a diverse group of researchers throughout the university and technology community to investigate these connections. He has participated in numerous projects investigating the metabolic implications of schizophrenia and of psychiatric medication including the association of antipsychotic medication with weight gain and insulin resistance.

    INSPIRE is an innovative interdisciplinary client-centered resource providing respectful evidence-based care to support people to achieve meaningful recovery from psychosis through collaborative partnership with individuals and their families while advancing knowledge and training for a new generation of providers. With a recovery-oriented philosophy, the clinic provides an array of services including psychopharmacology, psychotherapy, and psychosocial evaluations. As a research clinic, they are focused on collaborating with multiple disciplines throughout the university to conduct clinical and basic science research including functional imaging, clinical trials, basic pathophysiology, and genetics.

  • Christopher Patrick Caridi

    Christopher Patrick Caridi

    High-content Imaging Scientist, Sarafan ChEM-H

    Current Role at StanfordI am a High Content Imaging Scientist with Stanford's High-Throughput Screening Shared Facility (HTS @ the Nucleus), part of Sarafan ChEM-H and a shared resource of the Stanford Cancer Institute. Our mission is to give researchers access to fully automated high-throughput chemical, siRNA, cDNA, and high-content screening capabilities for both cell-based and enzyme/protein-based assays, accelerating the path from molecules to medicines.

    My work centers on high-content imaging and phenotypic screening. I serve as a project manager for all cell-based screens and lead assay design, development, validation, and deployment, along with robotic programming and automation, data management, and co-decision-making on major instrumentation acquisitions. I partner with investigators across Stanford to translate their biological questions into robust, scalable, imaging-based screens.

    The high-throughput screening (HTS) laboratory allows Stanford researchers and others to discover novel modulators of targets that otherwise would not be practical in industry. The center incorporates instrumentation (purchased with NCRR NIH Instrumentation grant numbers S10RR019513, S10RR026338, S10OD025004, and S10OD026899), databases, compound libraries, and personnel whose previous sole domains were in industry.

    Among our instrumentation are a fully automated Molecular Devices ImageXpress Micro Confocal High-Content fluorescence microplate imager, with live cell, fluidics and phase contrast options. Specializing in image analysis, data acquisition, and assay development with a focus on multiplexed imaging. Here to assist all screening needs as well as targeted analyses, mechanism of action deconvolution and utilizing spatial biology to uncover novel mechanisms.

    The HTS @ the Nucleus main screening lab is located in ChEM-H W008, the cell-based assay development lab is located in CCSR Room 0133-North Wing, between the Transgenic Mouse Facility, and the Stanford Genomics Facility.

  • Che-Hong Chen

    Che-Hong Chen

    Senior Research Scientist - Basic Life, Chemical and Systems Biology Operations

    Current Role at StanfordSenior Research Scientist
    CEO, International ALDH2 STAR Research Consortium
    Director of China, Singapore, and Taiwan Outreach, Center for Asian Health Research and Education Center

  • Hansen Chen

    Hansen Chen

    Instructor, Neurosurgery

    Current Research and Scholarly InterestsTranslational Stroke Research; Blood-Brain Barrier, Brain Immune Responses

  • Atman Desai, MD

    Atman Desai, MD

    Clinical Professor, Neurosurgery

    Current Research and Scholarly InterestsThe Stanford Spine Artificial Intelligence Laboratory develops data-driven technologies to improve diagnosis, surgical planning, and outcomes in spine care. Our research spans predictive modeling, computational imaging, spinal oncology, digital surgery, and real-world functional assessment using wearables. By integrating clinical, imaging, and functional data at scale, we aim to deliver clinically meaningful, patient-centered innovations for complex spinal disease.

  • Sebastian Duno-Miranda

    Sebastian Duno-Miranda

    Postdoctoral Scholar, Biochemistry

    BioI started my training as a biologist at the Universidad Central de Venezuela (UCV) and the Instituto Venezolano de Investigaciones Cientificas (IVIC). My Licentiate thesis degree advisor was Dr. Raúl Padrón, whom with I studied the structure and function of tarantula muscle, a key non-conventional animal model to understand muscle function in humans. Next, I would move to pursue doctoral studies at the University of Vermont, under Dr. David M. Warshaw supervision, studying the molecular mechanics of human cardiac myosin, the motor responsible for powering up the contractions of the human heart, the effect of multiple cardiomyopathy mutations, and the application of machine learning to enhance myosin single-molecule data analysis. Now, I've joined the lab of Dr. James Spudich at Stanford University, to continue pushing the frontiers of knowledge regarding the molecular physiology of human myosins in the context of heart disease. For more details please see https://duno-miranda.org

  • Yanan Feng

    Yanan Feng

    Sr. Research Scientist - Basic Life, Genetics

    Current Role at StanfordSenior Research Scientist, Department of Genetics, Dr. Stanley N. Cohen's lab

  • Daiana Fornes

    Daiana Fornes

    Life Science Research Professional 3, Obstetrics Anesthesiology

    BioDaiana Fornes is a postdoctoral scholar at Stanford University, supported by a Maternal & Child Health Research Institute (MCHRI) Postdoctoral Fellowship. Her research centers on reproductive biology and pregnancy disorders, with a particular focus on uterine contractility, preterm labor, and uterine atony. She investigates calcium signaling pathways, including the role of TRPV4 ion channels, to identify novel therapeutic strategies aimed at improving maternal health outcomes.

    Daiana earned her PhD from the University of Buenos Aires, where she studied metabolic alterations during pregnancy and their effects on fetal development. Her training has provided her with a strong foundation in translational research, with extensive experience in experimental design, molecular biology, and the analysis of signaling pathways.

  • Fumiaki Ikeno

    Fumiaki Ikeno

    Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine

    BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
    Researcher Cardiovascular Medicine, Stanford University
    Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
    Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University


    Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.

    After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.

    Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.

    Contact Information


    Falk CVRC CV007
    300 Pasteur Drive
    Palo Alto, CA 94305-5406

  • Kathy Johnson

    Kathy Johnson

    Executive Administrator, SPARK at Stanford

    Current Role at StanfordProgram Administrator, SPARK at Stanford
    Executive Admin to:
    Daria Mochly-Rosen, Professor
    Kevin V. Grimes, Professor - Teaching
    Department of Chemical & Systems Biology

  • Sharada Kalanidhi

    Sharada Kalanidhi

    Director of Data Science, Biochemistry - Genome Center

    Current Role at StanfordCurrent Research: Mathematical Medicine

    The essential challenge is not merely to solve a problem, but to discover the mathematical framework in which the problem can be understood — a perspective associated with the mathematician Alexander Grothendieck.

    We spent decades using sophisticated mathematics to understand financial markets. What happens when we bring that same mathematical direction—and deeper ideas from pure mathematics—to understanding human biology?

    This question captures the intellectual motivation behind Sharada's current work: developing the foundations of Mathematical Medicine, a proposed new discipline that draws on pure mathematics to address fundamental challenges in individualized diagnosis, personalized therapeutics, cancer treatments, and healthy longevity.

    The work begins with a central challenge in contemporary medicine. Advances in genomics, proteomics, metabolomics, and computational biology have generated unprecedented volumes of biomedical data. Yet translating these measurements into meaningful insights for individual patients remains difficult, particularly for those with rare, complex, or previously unexplained conditions.

    Conventional statistical and machine learning approaches have transformed biomedical research, but their reliance on population-level patterns can limit their usefulness when an individual patient's biology differs substantially from that of available reference cohorts. Clinically meaningful differences may be treated as statistical noise or outliers rather than investigated as potential clues to underlying disease mechanisms.

    After more than a decade of research and collaboration with biochemists at SGTC, Sharada became increasingly interested in whether the mathematical foundations used to interpret biomedical data were sufficient for the complexity of individualized medicine.

    Her central premise is that progress in personalized medicine may require not simply more data or larger computational models, but new mathematical ways of understanding biological systems.

    Rather than applying existing statistical approaches to biomedical problems, Mathematical Medicine explores whether ideas from pure mathematics can fundamentally change how biological questions are formulated, understood, and solved.

    The research is guided by the possibility that deeper mathematical understanding can reveal - and preserve- meaningful biological relationships even when data are limited, heterogeneous, or difficult to interpret using conventional approaches.

    This approach echoes a perspective expressed by the mathematician Mikhail Gromov: “This area does not yet exist. It will have to be invented.”

    It also reflects the empirical philosophy associated with the mathematician and quantitative investor Jim Simons: “We don't start with models. We start with data. We don't have any preconceived notions.” The aim is to allow biological observations to guide mathematical inquiry, rather than forcing them into existing computational frameworks.

    Sharada's research has contributed to investigations of complex and previously unexplained clinical conditions, including cases in which mathematical and multi-omic analyses helped identify potential diagnoses and therapeutic pathways. These investigations also motivate broader questions about how individual biological differences can inform our understanding of disease.

    The long-term vision is to establish Mathematical Medicine as a rigorous discipline connecting pure mathematics, molecular biology, and clinical medicine—advancing mathematics toward a foundation for understanding individual biology, preserving biological mechanisms and informing clinical decisions.

    Further information about Mathematical Medicine, its research vision, and opportunities for early philanthropic partnerships is available at:

    https://mathmed-2026.web.app/

  • Devanish Narasimhasanth Kamtam

    Devanish Narasimhasanth Kamtam

    Visiting Instructor, Cardiothoracic Surgery - Thoracic Surgery

    BioDr. Devanish Kamtam is a Visiting Instructor in the Division of Thoracic Surgery at Stanford University, working in Dr. Joseph Shrager's lab. His research focuses on surgical AI, AI in medical imaging, and clinical outcomes in Thoracic Surgery. He completed his MBBS at Gandhi Medical College, Hyderabad and MS in General Surgery at AIIMS New Delhi.

  • Jeewon Sylvia Kim

    Jeewon Sylvia Kim

    Program Manager, SPARK at Stanford

    Current Role at StanfordProgram manager for SPARK Translational Science Program overseeing educational seminar series, managing projects and facilitating SPARK global operations.

  • Bruce Koch, Ph.D.

    Bruce Koch, Ph.D.

    Director of High-Throughput Screening, Sarafan ChEM-H

    Current Role at StanfordDirector, ChEM-H/CSB High Throughput Screening Group
    Staff Lead, IMA HTS Module

    Adviser to the SPARK Program

  • Marc Leon (aka Hongliang Liang) MD, PhD

    Marc Leon (aka Hongliang Liang) MD, PhD

    Clinical Assistant Professor, Cardiothoracic Surgery

    BioMarc Leon (also known as Hongliang Liang), M.D., Ph.D., previously served as Chief Surgeon, Associate Professor of Cardiovascular Surgery, and Director of the Division of Coronary Artery Surgery at Xijing Hospital in Xi'an, China. Currently, he is a Clinical Assistant Professor in the Department of Cardiothoracic Surgery at Stanford Hospital. Dr. Leon is a surgeon member of the Society of Thoracic Surgeons (STS), the International Society of Heart and Lung Transplantation (ISHLT), and the Chinese American Academy of Cardiology (CAAC). His clinical and research expertise includes the surgical management of cardiopulmonary failure, heart valve disease, and ischemic heart disease, along with the application of stem cell therapy for myocardial infarction. Additionally, Dr. Leon is actively engaged in exploring the application of artificial intelligence in the field of cardiovascular diseases.

  • Joanna E. Liliental, PhD

    Joanna E. Liliental, PhD

    Director, TRAM, M-TRAM, TASC, Med/TRAM

    Current Role at StanfordExecutive Director, Master's in TRAM (M-TRAM)
    https://med.stanford.edu/tram/masters-program.html

    Director, Translational Applications Service Center (TASC)
    http://tasc.stanford.edu

    Associate Director, Translational Research and Applied Medicine (TRAM) Program
    http://tram.stanford.edu

    Senior Research Scientist, Stanford School of Medicine

    Instructor of University Courses: MED221,MED121, MED212A

    Member, Stanford Cancer Institute

  • Xin Liu

    Xin Liu

    Basic Life Science Research Scientist, Genetics

    BioXin Liu is a postdoctoral Research Scientist in the Department of Genetics at Stanford University. Xin holds a PhD in Chemistry from the University of Michigan, Ann Arbor. Her basic research interests include RNA and protein biochemistry, enzymology, cancer immunology, and autoimmune disease. She has published papers in several prestigious journals in the field of biochemistry, including Nature Communications, Journal of American Chemical Society, and Nucleic Acids Research. The highlight of her multidisciplinary research includes the development of high-throughput enzymatic methods to discover anti-microbial agents and to reveal mechanisms behind human mitochondrial diseases, as well as innovative applications of genome engineering and machine-learning to decode principles of RNA editing in human cells. Her current research focuses on the mechanistic study of innate immune pathways.

  • Antonio Meola, MD, PhD

    Antonio Meola, MD, PhD

    BioAntonio Meola M.D. Ph.D graduated Summa cum Laude and Research Honors at the University of Pisa, Italy, in 2008, and completed his residency training in Neurosurgery at the same Institution in July 2015. Dr Meola attended a Ph.D. program at the University of Florence, Italy, where he discussed a doctoral thesis entitled "A New Head-Mounted Display-based Augmented Reality System in Neurosurgical Oncology: a study on phantom".
    Since 2/2014 to 1/2015 Dr Meola completed a Research Fellowship in Neurosurgical anatomy at the University of Pittsburgh Medical Center (UPMC), under the Direction of Dr. Juan C. Fernandez-Miranda. The main focus of his research was the surgical neuroanatomy of the white matter tracts of the human brain.
    Since 7/2015 to 6/2016 Dr Meola served as Clinical Fellow in Image-Guided Neurosurgery at the Brigham and Women's Hospital, Harvard Medical School, in Boston, MA (Director: Dr. Alexandra J. Golby M.D.). During the fellowship, he focused on the clinical application and integration of advanced imaging techniques, including intraoperative-MRI, intraoperative US, functional MRI, tractography.
    Since 7/2016 to 6/2017 Dr Meola completed a Neurosurgical Oncology Fellowship at the Cleveland Clinic in Cleveland, OH, devoting his efforts to minimally-invasive neurosurgical techniques, such as Laser interstitial Thermal Therapy (LITT) and stereotactic radiosurgery (Gamma Knife), as well as to awake neurosurgery.
    Starting 7/2017, Dr Meola joined the Department of Neurosurgery at Stanford. Dr. Meola mainly focuses on conventional and innovative treatments for brain and skull base tumors, including both surgery and stereotactic radiosurgery (CyberKnife).

  • Pardis Miri

    Pardis Miri

    Basic Life Research Scientist, Genetics

    BioPardis Miri, PhD, is a Research Scientist and former Postdoctoral Fellow at Stanford University, where she develops technology aimed at improving mental well-being. She holds a PhD in Computer Science and has extensive training in affective science under Professor James J. Gross. Pardis leads a multidisciplinary team (http://wehab.stanford.edu
    ) conducting clinical and real-world studies to assess how wearable technologies can reduce stress and enhance glymphatic flow in early-stage Alzheimer’s patients.

    During her postdoctoral work, Pardis served as the principal investigator of FAR, a multi-disciplinary project to design, build, and evaluate an end-to-end wearable system for children with emotion dysregulation, including those diagnosed with autism spectrum disorder. FAR aims to support more adaptive emotion-regulation strategies through a combination of systems design and behavioral research.

    Pardis is advised by Professors Michael Snyder, Keith Marzullo, and James J. Gross, and collaborates with Professor Antonio Hardan of the Stanford School of Medicine on research involving children with autism spectrum disorder.

  • Dhriti Nagar

    Dhriti Nagar

    Postdoctoral Scholar, Neonatal and Developmental Medicine

    BioPremature birth is a leading cause of developmental and neuropsychiatric disorders in children. One of the factors causing these defects is lowered levels of available oxygen (hypoxia) in the newborn due to immature lungs. My research focuses on understanding the cellular and molecular mechanisms underlying hypoxia-induced developmental disorders of the nervous system due to preterm birth.

  • Michitaka Nakano

    Michitaka Nakano

    Basic Life Research Scientist, Medicine - Med/Hematology

    BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.

  • David J. Park, MD, PhD, FCNS

    David J. Park, MD, PhD, FCNS

    Clinical Assistant Professor, Neurosurgery

    Current Research and Scholarly InterestsOur research ecosystem bridges clinical outcomes, translational organoids, and surgical intelligence:
    (1) A Clinical Neuro-Oncology Dry Lab investigating outcomes and trials for CyberKnife radiosurgery and minimally invasive brain tumor surgery,
    (2) A Radiosurgical Organoids Wet Lab modeling radiobiology, radiomodulators, and genetics, and
    (3) A MedTech Innovation Lab at VA Palo Alto developing intraoperative digital twins, surgical video analytics, and optical navigation, etc.

  • Suraj Pavagada

    Suraj Pavagada

    Postdoctoral Scholar, Radiology

    BioSuraj Pavagada is a postdoctoral scholar at the Department of Radiology at Stanford University. His research focuses on exploiting magnetic levitation and optoelectronic techniques for applications in medical diagnostics.

    Suraj received his PhD in Oncology from the University of Cambridge (24’), where he developed a new bioelectronic cell enrichment platform utilizing altered glycosylation patterns for the early detection of esophageal cancer. With a background in electrochemistry, surface functionalization, liquid biopsy, and molecular diagnostics, he is passionate about developing portable sensor technologies that can be translated into the clinic to facilitate timely diagnosis and monitoring.

  • Neda Sattarnezhad Oskouei, MD, MS

    Neda Sattarnezhad Oskouei, MD, MS

    Instructor, Medicine - Immunology & Rheumatology

    BioDr. Neda Sattarnezhad Oskouei is a board-certified neurologist and neuroimmunologist specializing in Multiple Sclerosis (MS) and neuroimmunological disorders, including Neuromyelitis Optica (NMO), MOG Antibody Disease (MOGAD), optic neuritis, transverse myelitis, autoimmune encephalitis, neuro-rheumatological conditions, and neuroinfectious diseases. Her research focuses on understanding the role of pathogens in triggering autoimmunity, with a particular emphasis on the role of Epstein-Barr Virus (EBV) in the development of MS.

    Dr. Sattarnezhad earned her MD degree with honors from Tabriz University of Medical Sciences. She completed a research fellowship in Multiple Sclerosis at the Brigham MS Center, Harvard Medical School, before pursuing her residency in adult neurology at the University of Illinois at Chicago. She further specialized by completing a clinical fellowship in Multiple Sclerosis and Neuroimmunology at Stanford University as a Sylvia Lawry Fellow of the National MS Society, during which she also earned a master’s degree in Epidemiology and Clinical Research. She subsequently completed a fellowship in immunology and rheumatology at Stanford.

    Her research and training have been supported by the National MS Society (NMSS), National Institutes of Health (NIH), and National Institute of Allergy and Infectious Diseases (NIAID).

  • Tanya Sharma

    Tanya Sharma

    Postdoctoral Scholar, Pathology

    BioTanya's interests span across studying G-Protein Coupled Receptors and the biochemistry of membrane proteins. During her doctoral studies, she worked as a visiting researcher at the National Research Council of Canada, Ottawa (Sussex laboratories) from 2019-2023 uncovering the role of an ancient mating receptor Ste3 in microbial pathogenesis and chemotropism. During her current position at Butcher lab, she is using High Performance Computing (HPC) platforms to guide her search for interesting ligand-receptor interactions. This involves using a combination of computation tools, cell based and analytical chemistry techniques for discovery and validation phase respectively.
    Outside of science, she is an avid musician and a singer.

  • Parveen Shiraz, MD

    Parveen Shiraz, MD

    Instructor, Medicine - Blood & Marrow Transplantation

    Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation-Cell Therapy (BMT-CT) at Stanford University. The focus of my laboratory research is the exploration of safe and more accessible forms of cell therapy for myeloid malignancies. We are studying multi-antigen targeting antibodies and engineered Natural Killer cells for myeloid malignancies.

  • Sean Paul Spencer, MD,PhD

    Sean Paul Spencer, MD,PhD

    Assistant Professor of Medicine (Gastroenterology and Hepatology)

    BioSean Spencer, MD,PhD is a Gastroenterologist and Physician Scientist at Stanford University working to uncover the role of dietary intake on the gut microbiome and mucosal immune system. Sean obtained his medical degree University of Pennsylvania, earning his PhD studying nutritional immunology with Yasmine Belkaid,PhD at the National Institutes of Health (NIH), after which he moved to Boston for residency training at Massachusetts General Hospital and completed his Gastroenterology training at Stanford University. Sean’s career goal is to study mechanisms by which dietary intake influences our microbiome and immune system to better understand and treat gastrointestinal disease. Sean has launched a microbiome-focused clinical practice at Stanford where he is working to develop novel microbiome diagnostics and microbial medicines.

  • Yonatan Winetraub

    Yonatan Winetraub

    Instructor, Structural Biology

    Current Research and Scholarly InterestsMy interests span non-invasive imaging for early cancer diagnosis and space exploration.
    I'm focusing on utilizing Optical Coherence Tomography (OCT) and machine learning to create virtual histology tools to image cancer non invasively at a single cell resolution, allowing physicians to skip biopsy (read more about the research). Prior to my PhD at Stanford, I co-founded SpaceIL, a non-profit organization that launched the first private interplanetary robotic mission to the Moon launched 2019.

  • Mang Yu

    Mang Yu

    BioDr. Yu is contributing to growing the School of Medicine’s portfolio of grants, especially those related to biomedical data science
    https://orcid.org/0000-0003-3302-3180